| 中文名称 | (11aS)-10,11,12,13-四氢-5-羟基-3,7-双(1-芘基)-二茚并[7,1-de:1',7'-fg][1,3,2]二氧磷杂八环 5-氧化物 |
|---|---|
| 英文名称 | (11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-1-pyrenyl-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 5-oxide |
| 英文别名 | J3.543.927G;(aR)-6,6'-Di(1-pyrenyl)-7,7'-(hydroxyphosphinylidenebisoxy)-1,1'-spirobiindan;(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-1-pyrenyl-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosph;Diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 10,11,12,13-tetrahydro-5-hydroxy-3,7-di-1-pyrenyl-, 5-oxide, (11aS)-;1643684-81-4;1643684-79-0;G69762;G65409;(11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-1-pyrenyl-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 5-oxide;(11aR)-3,7-Bis(1-pyrenyl)-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 95%, (99% ee);MFCD31720599;(11aS)-3,7-Bis(1-pyrenyl)-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin;(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-1-pyrenyl-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 5-oxide;Diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 3,7-bis[4-(1,1-dimethylethyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-, 5-oxide, (11aS)-;CS-0197946;MFCD31707581;EX-A7943H;Diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 10,11,12,13-tetrahydro-5-hydroxy-3,7-di-1-pyrenyl-, 5-oxide, (11aR)-;(S)-12-hydroxy-1,10-di(pyren-1-yl)-4,5,6,7-tetrahydrodiindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocine 12-oxide;CS-0197929;EX-A7943K |
| CAS号 | 1643684-79-0 |
| 分子式 | C49H31O4P |
| 分子量 | 714.74 |
微信公众号
版权所有：济南迈纳科技有限公司 未经授权禁止拷贝本站资料，如有违反,将追究法律责任
备案号： 鲁ICP备2021031564号-1 危险品化学品经营许可证 营业执照
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的，不可用于人类或动物的临床诊断或治疗，非药用，非食用。
